1. Home
  2. TS vs DGX Comparison

TS vs DGX Comparison

Compare TS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenaris S.A.

TS

Tenaris S.A.

HOLD

Current Price

$56.42

Market Cap

27.3B

Sector

Industrials

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$233.79

Market Cap

23.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TS
DGX
Founded
2001
1967
Country
Luxembourg
United States
Employees
24875
N/A
Industry
Steel/Iron Ore
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.3B
23.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
TS
DGX
Price
$56.42
$233.79
Analyst Decision
Buy
Buy
Analyst Count
5
13
Target Price
$58.80
$214.38
AVG Volume (30 Days)
1.0M
1.0M
Earning Date
05-06-2026
04-21-2026
Dividend Yield
2.80%
1.82%
EPS Growth
N/A
13.78
EPS
N/A
5.08
Revenue
N/A
$11,035,000,000.00
Revenue This Year
$1.53
$7.53
Revenue Next Year
$3.59
$3.77
P/E Ratio
$12.59
$46.30
Revenue Growth
N/A
11.78
52 Week Low
$33.71
$167.96
52 Week High
$64.60
$240.13

Technical Indicators

Market Signals
Indicator
TS
DGX
Relative Strength Index (RSI) 44.57 75.45
Support Level $53.44 $190.42
Resistance Level $60.01 N/A
Average True Range (ATR) 1.14 6.80
MACD 0.16 2.64
Stochastic Oscillator 18.50 87.45

Price Performance

Historical Comparison
TS
DGX

About TS Tenaris S.A.

Tenaris SA is engaged in the manufacture and supply of steel pipe products and related services for the energy industry and other industrial applications. The company has one reportable segment, Tubes, which includes the production and sale of steel tubular products such as OCTG, line pipe, and mechanical and structural tubes, mainly for the oil and gas industry. It operates an integrated network of manufacturing, research, and service facilities across the Americas, Europe, the Middle East, Asia, and Africa.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: